Information about the global medicine supply chain is fragmented and disparate, and hospitals often learn about drug shortages too late in the planning process.

There were 114 new drugs shortages in 2021 according to ASHP.1 Drug shortages result in an estimated $360 million of labor expenses per year for hospitals.2 When medicines are not available, patients face an increased risk of medication errors and adverse patient outcomes.3


Hospitals deal with many urgent issues daily; having easy access to critical information about the drug supply chain can help mitigate drug shortage issues that arise.


Medicine Supply Map Insights can provide early answers on drug products and API manufacturers' locations. Over 80% of United States active pharmaceutical ingredients (APIs) and drug product manufacturers' locations are identified within the data – and API manufacturers are traced for 40% of US Rx labels. This essential data can help prioritize drugs at highest, long-term risk of shortage with the supply chain vulnerability scores. Medicine Supply Map Insights is updated on a monthly basis, so your health-system can remain informed on the impacts of drug shortages.


1. Fox, E. R., National Drug Shortages: New Shortages by Year January 2001 to June 30, 2022. ASHP and University of Utah Drug Information Shortage. 

2. Vizient Drug Shortages Task Force. (2019). Drug Shortages Labor Cost Report.

3. Fox, E. R., Sweet, B. V., Jensen, V. (2014) Drug Shortages: A Complex Health Care Crisis.


Give yourself time to plan with USP Medicine Supply Map Insights. Apply to become an early user and receive a sample data set.



Application does not guarantee acceptance into the early user program. By providing your contact information to USP,  you consent to be contacted by USP. You may opt out at any time by following the instructions included in every email alert sent to you by USP. You further agree to terms of USP’s Privacy Policy.